CA2157416A1 - Method for enhancing detection ability of nucleic acid assays employing nucleic acid sequence based amplification - Google Patents
Method for enhancing detection ability of nucleic acid assays employing nucleic acid sequence based amplificationInfo
- Publication number
- CA2157416A1 CA2157416A1 CA002157416A CA2157416A CA2157416A1 CA 2157416 A1 CA2157416 A1 CA 2157416A1 CA 002157416 A CA002157416 A CA 002157416A CA 2157416 A CA2157416 A CA 2157416A CA 2157416 A1 CA2157416 A1 CA 2157416A1
- Authority
- CA
- Canada
- Prior art keywords
- rna
- dna
- nucleic acid
- nasba
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 61
- 150000007523 nucleic acids Chemical group 0.000 title claims abstract description 52
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims abstract description 31
- 238000001514 detection method Methods 0.000 title claims abstract description 31
- 230000003321 amplification Effects 0.000 title claims abstract description 9
- 238000003199 nucleic acid amplification method Methods 0.000 title claims abstract description 9
- 230000002708 enhancing effect Effects 0.000 title abstract description 4
- 238000007826 nucleic acid assay Methods 0.000 title description 2
- 108020004414 DNA Proteins 0.000 claims abstract description 74
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 10
- 230000000984 immunochemical effect Effects 0.000 claims abstract 4
- 239000007787 solid Substances 0.000 claims description 7
- 229920002477 rna polymer Polymers 0.000 abstract description 58
- 102000053602 DNA Human genes 0.000 abstract description 18
- 102000039446 nucleic acids Human genes 0.000 abstract description 18
- 108020004707 nucleic acids Proteins 0.000 abstract description 18
- 238000003556 assay Methods 0.000 abstract description 9
- 238000004458 analytical method Methods 0.000 abstract description 7
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 108091027305 Heteroduplex Proteins 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 13
- 244000052769 pathogen Species 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- 235000013305 food Nutrition 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000007790 solid phase Substances 0.000 description 11
- 108020004682 Single-Stranded DNA Proteins 0.000 description 8
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 8
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 8
- 239000003298 DNA probe Substances 0.000 description 7
- 239000000427 antigen Substances 0.000 description 7
- 108091093088 Amplicon Proteins 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 229930024421 Adenine Natural products 0.000 description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- 108020003215 DNA Probes Proteins 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 229960000643 adenine Drugs 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 229940104302 cytosine Drugs 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 108020004418 ribosomal RNA Proteins 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- -1 Iysozyme Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 108091028733 RNTP Proteins 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 125000003636 chemical group Chemical group 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 231100001261 hazardous Toxicity 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 101100260171 Comamonas testosteroni tesE gene Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 241000962035 Petrocodon lui Species 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
This invention relates to a new and novel method for significantly enhancing the sensitivity of assays aimed at detecting the presence of target deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequences in a sample. Specifically, this method applies to techniques that employ nucleic acid sequence based amplications (NASBA?) or other nucleic amplification techniques to amplify copies of the target RNA or DNA (Sooknanan et al., Bio"Techniques, 17: 1077-1085, 1994) to allow for detection. The method of the present invention combines the following three steps for the first time: RNA amplification using NASBA; RNA:DNA hybrid formation; and immunochemical detection of heteroduplex nucleic acid sequences. This method extends the standard NASBA techniques to accommodate amplification of copies of the NASBA product, which, following binding to DNA sequences facilitates immunochemical detection of the RNA:DNA hybrids thereby formed. This combination of steps results in a new assay with increased simplicity, speed and sensitivity, including a greatly improved signal-to-noise ratio, over standard nucleic acid detection methods. This improved method will be extremely useful for performing analyses in the forensic, clinical, agricultural and biological fields.
Description
21~74~6 .
METHOD FOR ENEIANCING DETECTION ABILITY OF NUCLEIC ACID ASSAYS
EMPLOYl~G NUCLEIC ACID SEQUENCE BASED AMPLIFICATION
BACKGROUND OF TEIE INVENTION
The present invention relates to improved methods of detecting specific nucleic acid sequences. Examples of nucleic acid sequences are d~-y~ ..u,,l~.~, acid (DNA) and ribonucleic acid (RNA) sequences. The molecular subunits of both DNA and RNA are called 10 nucleotides which are linked together to form long poly ' ' chains. Each nucleotide subunit is made of a sugar moiety, a phosphate moiety and a bæe moiety. It is the sequential ordering of the bæe moieties [adenine (A), cytosine (C), guanine (G), thymine (T), uracil (U)]
that contains DNA or RNA's genetic illrUl The ordering of these base moieties in a p~ly ' ' chain and the tendency of the bæes to attract and bond with other specific bæe 15 moieties, is exploited by this invention to locate, detect and isolate specific DNA or RNA
sequences.
DNA l-ormally contains two poly,.u.,l~,u~ , stMnds twisted about one another lengthwise in a helical manner resembling a ladder where the sides are made of identical sugar 2 0 (deu--y. il,~se) and phosphate molecules while the rungs are made up of bæes extending out from each stMnd, held together by weak attractive forces. In DNA, the base thymine on one stMnd always pairs with the bæe adenine on the opposing strand, and the base guanine always pairs with the bæe cytosine. This is called Culll~ lLaly bæe pairing.
RNA is also a p~ly ': '- strand. However, the sugar moiety is ribose (versus d~u~yl i~ose in DNA) and the bæes are adenine, guanine, cytosine and UMCil. In RNA, the bæe uracil on one strand can pair with the bæe adenine on the opposing stMnd, and the bæe guanine can pair with the bæe cytosine. Although RNA can pair with either a cc-~lr' y stMnd of RNA or DNA, it is normally single stMnded so does not form a helical structure.
2I~7~1 6 .
Techniques for detecting and/or isolating particular nucleic acid sequences of interest have increase~ in popularity during recent years especially in terms of application for detecting the presence of the DNA or RNA within pathogens such as viruses, bacteria, or other UU16~111;,~111~ and therefore the presence of these pathogens themselves. These techniques can 5 also be used for other purposes such as to screen bacteria for antibiotic resistance, to aid in the diagnosis of genetic disorders (for example in sickle cell anaemia and th~ ), and to detect cancerous cells. Several a~J~J' have been developed for the ~ ,lùbiu106i~,~1 analysis of clinical, food, Cl.viUI I, and forensic samples. A general review of a technique and its present and future v is provided in Bi~ nlngy (August 1983), pp. 471-478 0 which is i.,~ul,uul~L~d herein by reference.
One situation in which it is desired to detect the presence of target nucleic acids involves the detection of pathogens by means of diagnostic tesE which claims a large share of the health care market and the agri-food industry. The definitive ' ~ of microbial pathogens in i ~ ., ' (e.g., foods) and clinical specimens requires the observation of the infectious agents or their -~ ~lr , soch as specific antigens or nucleic acid (DNA or RNA) sequences. The traditional culture methods for the detection of pathogens are slow, expensive and labour-intensive.
2 o To overcome these di ,~lv ~ , simple and rapid methods exploiting new Ir~
have been developed for detecting the presence of pathogens of medical, c..~/iu~ ' and a6li ' ' importance which appear in sample matrices (e.g., foods) at very low Several ' O ' tests are now available which exploit the specificity of the antibody-antigen reaction, namely, ~' tests, nuul~...,e tests and ~., (e.g., Id.li~ ~, enzyme ~,.).
~ " y employs a radioactive isotope as the label. Because of the ;II~UA.~. , hazard and difficulty of handling radioactive materials, assay systems have been devised using labels other than ,~ ,.- as the label comronPnt, including enzymes, 3 o 1,~~ , metals and organo-metallic comple~es, co-enzymes, enzyme substrates, enzyme ~1~7416 activators and inhibitors, rh~mil ' ' reactants, fluorescent molecules, and others.
Enzyme ~O use enzyme-labelled ~Cllio (antibodies or antigens) for detection of antigens or antibodies captured on a solid phase. In this technique, enzymes (e.g., 5 peroxidase, alkaline 1' . ' ) are covalently linked to a detector ~g~ (e.g., an antigen-specific antibody) by using a cross-linking agent, such as, ' ' ' ' yJ~ or a procedure such as periodate oxidation. Adsorption onto an easily l~iCu..,l~le solid phase provides for a simple and rapid means of ~;li~iu.. of VU,~ I for the subsequent capture of antigens or antibodies from a test sample. Since antibodies and antigens contain l~yd~ ic 10 regions in their structures, they bind readily to l~yJIu~Jll~ic surfaces. Most commonly used enzyme y~ depend on the adsorption of ~Ab~ onto either a flat solid phase, a ~UIUUo surface, or a Il~ ,lUlJVIUUo surface such as polyester cloth. Solid phases, e.g., microtiter plates, tubes or beads, and plastics, e.g., pulyoIyl~ " polyvinyl chloride, nylon and poly,l,~ "y' have been commonly used.
Another approach commonly used for pathogen detection involves the use of a nucleic acid probe (DNA or RNA) labelled with a detector moiety (e.g., ~ , chemical label such as ~'iv v or biotin, enzymes, fluorescent markers, etc.), which can be hybridized with IIUE,~.. specific nucleic acid sequences ' ~ 1 on a solid phase (e.g., membrane or microtiter plate). The hybridized probe is then measured by detecting the presence of the detector moiety.
Yet another more recently developed approach for detecting pathogens involves the use of nucleic acid sequence based ~ lirl~ iull (NASBA), described in United States patent 5,409,818 for the a"",l ~ of unique nucleic acid sequences of bacteria and other t~rget cells. The advantages and limitations of this technique have been reviewed by van Gemen (J.
Virol. Metho~s, 43: 117-188, 1993, i,.~u,~ ' herein by reference). This powerfultechnique, which uses can achieve ~..,.,.~,..Ju . amplification of very low numbers of target nucleic acids to levels which can be easily visualized by vl~llU~lllUl~ analysis or by 30 llybli.li~dtiOIl with a DNA probe.
~ 2~7~16 The . ' of specific RNA sequences generated by the NASBA technique has been widely applied to the rapid and sensitive detection of bacterial pathogens. Although NASBA has great potential as a very sensitive and specific technique, it has not always been possible to ællieve this level of sensitivity in its application to the detection of pathogens directly 5 or in U.ll ' cultures of food and e.~ ' samples.
The sensitivity of the NASBA could be enhanced by detection of the product using DNA
probes tdrgeting the amplified sequences (such as the ' ' 'o,,y described in Holstrom 11..
1993, Anal. Biochem., 209:278-283). However, such methods usually involve labour-intensive 0 DNA-DNA l~ylJIiJ;~Liu procedures and require the use of probes labelled with detectable chemical or radioactive moieties, which can be costly to prepare and difficult to ~ Ldi~.
r, Lh~,,l.lUI~, DNA probes targeting the NASBA product sometimes only produce a moderate . U~ in the sensitivity of the test, which may still require more than ten to several hundred cells per reaction in order to give a detectable signal.
One way of enhancing signal amplification entails tdrgeting RNA. An example of target irl~liu., entails assaying for ribosomal RNA (rRNA) of a UUlo~lll; ..l rather than ' ul.lù ~VIlldl DNA. Since rRNA is present in any given cell at 104 times higher ~
than DNA, the number of possible target sequences increases, thereby increasing the probability 2 o of detecting the target organism. However, this approach suffers from the limitation of the type of RNA sequences being expressed and therefore not completely suitable.
Yet another i iL"iol~-based; .,lirl~Liu.l system utilising ~B-replicase can produce a 2-5 million-fold ~ rl~,iull of a given target after 4 cycles (Li~ardi et al., B- ' ' Oy 6, 1197-1202, 1988). However, this technique suffers from such problems as excessive noise, false positives, requires ~ ' ' ' technical expertise, and relatively expensive il..,.
and reaOents (Walcott et al. J. Food Prot. 54:387-401, 1991).
Accor~ingly, those concerned with the dl~v~ '(I and application of NASBA-based 3o diagnostic tests have recognized the need for simple, non-hazardous L~ for ~ v ~1~7416 .~
the sensitivity of NASBA tests. r. ih.,.lllvl~;, there is a great need for ~ methods for detecting pathogens, rather than the purely qualitative approaches currently being practised, since it is often necessary to estimate the degree of microbial hazard associated with a sample (e.g., foods) on the basis of the level of Therefore, there is a great need for simple and ill~.A~ methods to augment the sensitivity and reliability of NASBA tests, ~ ,ulally for the forensic sciences, the food industry, clinical d~licdLio.~ and other users who must routinely process large numbers of samples containing very few target cells. It is therefore an object of the present invention to 0 provide a method for the . ' of NASBA for specific pathogens without the need for ill~Vl~Ul~llil." hazardous " ~ "~ or expensive (and potentially umreliable) chemical labels in the nucleotide transcripts to permit their subsequent detection.
A furtller object of this invention is to provide a very simple and user-friendly detection 15procedure for the products of the NASBA.
Yet another object of this invention is to provide for the 4u~ liv~ assay of pathogens in a sample by using the combined target nucleotide; ' method and detection procedure described above.
~ , In accordance with the present invention and as used herein, the following terms are defined with the following meanings, unless explicitly stated otherwise.
The term "amplicon" refers to a fragment of DNA or RNA spanned within a pair of annealing primers; this fragment is amplified 1AIJV '' ~Iy by the enzyme DNA pol~-ll.,l~s~.
The term "i .: ' . ' " refers to a procedure for s ~ ~ 'y enhancing the number of copies of RNA sequences that are ~v~ y to DNA amplicon sequences ~1~741~
by ~ of those amplicon sequences into many copies of RNA by using an dl)lJlU~JI' ' RNA polymerase.
The term "lldiL~ i' I reaction mix" refers to RNase-free deionized distilled water containing 80 mM Tris-HCI (pH 7.5), 12 mM MgCIl, 4 mM ~. " , 20 mM NaCI, 20 mM
(1, 1 mM of each rNTP (Promega, No. P1221), 10 units of T7 RNA pOIylK~
(Promega, No. P2075) and 20 units of RNasin (Promega, Nû. N2511) per 25 ,ul).
The term "NASBA " refers to a process for amplifying a specific nucleic acid sequence, involving; ~y ' ~ single-stMnded RNA, single stranded DNA and double-stranded DNA;using the single-stranded RNA as a first template for a first primer, using the single-stranded DNA as a second template for a second primer, and using the double-stranded DNA
as a third template for synthesis of a pluMlity of copies of the first template; a sequence of the frst primer or the second primer is cu."~' y to the sequence of the target nucleic acid and a sequence of the first primer or the second primer is h~m~r~--c to a sequence of the target nucleic acid. NASBA is used to increase the quantity of the target nucleic acid sequence to allow detection or to increase the purity of such a target nucleic acid sequence.
The term "target nucleic acid sequence" refers to any DNA or RNA sequence that is desired to be detected.
SUMMARY OF TE~E INVENTION
This method applies to techniques that employ nucleic acid sequence based ~
(NASBA) to amplify copies of the target RNA or DNA to allow for detection. This method combines the following three steps for the first time: nucleic acid , ' ' using NASBA
of a target nucleic acid sequence; RNA:DNA hybrid formation; and ' ' detection of i,~,~,ludu~ ,A nucleic acid sequences. This metbod extends the standard NASBA techniques 2~S7~1 6 to r~ ---- ' ' the .~ r~ O~. of copies of the NASBA product, which, following binding to immobilized probe DNA sequences facilitates ' ' detection of the RNA:DNA
hybrids thereby formed.
FIGURES
Figure I is an Agarose gel Clc~,ll, . ' ~i~ of the NASBA reactions.
Figure 2 is graphic l~l~ of various COI~ " of NASBA products detected 0 by anti-HNA-antibody.
DETAILED DESCRIPTION OF THE INV~ON
The method described in this invention applies to techniques that employ nucleic acid 5 sequence based A~ lir~ . - (NASBA) to amplify copies of target RNA or DNA sequences to allow for their detection. This invention constitutes an exterlsion beyond the prior art rendering nucleic acid sequence detection more feasible and reliable while ~ improving thesignal-to-noise ratio of these techniques. This improvement is especially notable in situations where a target nucleic acid sequence is present as a minute component of a mixture of nucleic 2 o æid sequences or is present at low levels.
The method of the present invention combines the following three steps for the first time:
target nucleic acid ~ lirl~liol~ using NASBA; RNA:DNA hybrid formation; and - I detection of l~ `UdU~ A nucleic acid sequences. This method extends the 25 standard NASBA techniques to r ' ' the I .,lir~ ,.. of copies of NASBA RNA
product, which, following binding to DNA sequences facilitates ' ' detection of the RNA:DNA hybrids thereby formed.
In the first step of this invention, a nucleic æid sequence based r ~ l r ~' (NASBA) 30 process is used for amplifying a specific nucleic acid sequence, which involves: ~
2L ~7~ ~ 6 . ~
single-stranded RNA, single stranded DNA and double-stranded DNA;using the single-stranded RNA as a first template for a first primer, using the single-stranded DNA as a second template for a second primer, and using the double-stranded DNA as a third template for synthesis of a plurality of copies of the first template; a sequence of the first primer or the second primer is 5 : , l y to the sequence of the target nucleic acid and a sequence of the first primer or the second primer is l~n ~ ,JII!~ to a sequence of the target nucleic acid.
In the second step of this invention, RNA:DNA hybrid formation, advantage is taken of the fact that RNAis produced directly from NASBA, allowing the target nucleic acid sequences 0 to once again be selected out of b~h~,-uu--d nucleic acid sequences by ll,~/blil]i~illg the RNA
sequences to , ' y DNA probes attached to a solid support, to generate ' ili~d RNA:DNA hybrids. This allows for washing away of extraneous material.
The h~uduL~h,~ nature of the nucleic acids sequences allows for the use of antibûdies 15 that specifically recognize RNA:DNA hybrids and can be used to detect the hybrids in one of many ' ' methods of analysis. This antibody can possess a chemical group allowing for direct detection of the hybrids, or it can also be detected indirectly using another antibody to which a chemical group is attached, that recognizes the anti-RNA:DNA antibody.
t~; I r~r,~ - ,.1 Inll In one particular ~,...1,, ' ~, the sample to be tested is typically a piece of food, for example meat or cheese, or another source containing single or double stranded nucleic acids.
25 This includes ~ ,luu~ and/or other cellular material associated with these samples. The test sample is first treated to release the nucleic acids from the cells, followed by a step to denature the r~ucleic acids. This is typically accomplished by Iysing the cells in a Iysis buffer solution and the ~' of nucleic acids is preferably , ' ' ' by heating the resulting solution in boiling water or alkali treatment (e.g., 0.1 N sodium hydroxide). The denaturing step can often be used ' '~, with the Iysis method. The release of nucleic acids can, 21~ ~41 ~
.
also, be obtained through mechanical disruption such as free~ing/thawing, abrasion, sonication, physical/chemical disruption (eg. ~olyu~yc;al~lc.le ether detergents like Triton~, pulyu~.yal~ ulbiL~LIl detergents like Tween~, sodium dodecylsulfate, alkali treatment, osmotic shock, heat, or Iysing using enzymes such as proteinase K, Iysozyme, pepsin). The 5 resulting medium will contain nucleic acids in single stranded form which is then assayed according to present llyblidi~LIiu.. methods (Wang et al., Appl. Environ. Microbiol., 1992).
When the sample contains free single-stranded RNA sequences, the sample is in proper form for NASBA. If the sample contains a tuget sequence that is a free single-stranded DNA
10 sequence, then Lldl,.,~ iul. must first occur to generate the desired RNA sequence. When the assay is performed for detection of a Illi~,lU~ ,. , a bacterium for example, the cells must be Iysed and the nucleic acids have to be exposed in order to be available for llybl iJi~dtiu.. with the priming ~ . Methods of Iysis have been previously described and are well known to one skilled in the art.
RNA Amplifirotin~l ~ N~ R~
Target RNA is amplified by NASBA procedure (or the d~JlJlUlJI- ' RNA sequence must be generated from the target DNA). A standaud NASBA reaction mixture contains T7 RNA
20 pulyll.~.~se,RNaseH,AMVreverseLIdll,~ L~ nucleosideLlr~ ~' ,twoseparatespecific primers and dl~JIU~Jl buffer -ml One of the primers (Primer 1) is prepared with the T7 promotor sequence appended to its 5' end.. The reaction Lr ' has been previously described ( B. van Gemen et al, J. Vuol. Methods, 43: 177-188, 1993; European Patent No:
0329822).
In this process, single-stranded RNA is converted to single-stranded DNA which in turn is converted to a functional template for the synthesis of a plurality of copies of the original single-stranded RNA. A First primer and a second primer are used in the ~mrlifiroti~-~ process.
A sequence of the fust primer or the second primer is ,urrl~;~.lLly . y to a sequence 30 of the specific nucleic acid sequence and a sequence of the first or the second primer is 7 ~ 1 ~
sufficiently l~ ."~ to a sequence of the specific nucleic acid sequence. In some instances, both the first primer and second primer are rr ' '~ ' y and s~fr~
e.J--- to a sequence of the specific nucleic acid sequence, for example, if the specific nucleic acid sequence is double stranded DNA.
The RNA is converted to single-stranded DNA by l.yb- idi~ g an r~ ul ~rl~ primer(the first primer) to the RNA (the first template) and ~yllLh~i~illg a ~ . ' y strand of DNA from the first primer, (the first DNA sequence) by using a RNA-directed DNA
pol~ l~e. The resulting single-stranded DNA (the second template) is separated from the first template by, for example, hydrolysis of the first template and by using a l;l.. ". l;~.~ which is specific for 12NA-DNA hybrids (for e~ample, .i~ . H). The second template is converted to a form which is capable of RNA synthesis by l.~. idi~illg a syntbetic r~ ,J"", l~Ol ir~,S (the second primer), which contains at its 3' end a sequence which is rr- ~ Iy IL~Y to the 3' end of the second template and toward its 5' end a sequence containing 15 the antisense strand of a promoter and antisense sequence of a lldlr~ UliOI~ initiation site, and by Sy..a.~ i,.g a second DNA sequence covalently attached to the 3' end of the second primer using the second template as a template and ~ ih~i~illg a third DNA sequence covalently attached to the 3' end of the second template using the second primer as a templated, using DNA-directed DNA p~lylllci~. The resulting functional derivative of the second template, 20 which is a third template, is used for the synthesis of a plurality of copies of RNA, the first template, by using a RNA p~l~lll.,l~e which is specific for the promoter and LlL~ iUII
initiation site defined by the second primer. Each newly ~yllal~i~d first template can be converted to further copies of the second template and the third template by repeating the cycle.
In addition, repetition of the cycle does not require ~ ioll or . . I by the user.
RNA:DNA Hybri~l Forr~irn Once the NASBA method has generated an ~lUL" number of copies of the target nucleic acid sequences of interest, the NASBA products will be digested using an ~JIU~II' ' restriction; ' ' (eg. Hind lll) to cleave off the primer- l' y sequences, 215~41 6 leaving target-~ , ' y nucleic acid sequences for use as probes. These probes will be ~urr..,;~ ly long (typically greater than 16 nucleotides) and ~urr~ , ' y to thetarget nucleic acid sequences to allow for efficient binding of transcribed amplicons to generate T~NA:DNA hybrids.
The probes thereby created can be attached to solid supports such as microtiter wells, "dip sticks~, or III.I~,IUI,JvlU.I. polyester cloth. Modes of nucleic acid sequence attachment to various forms of solid supports are well known in the art. The primary objective of the mode of attachment chosen is to allow for secure attachment of the nucleic acid to the support while 10 allowing for future efficient binding of cu.ll~' y sequences.
The probe may be denatured by heating and then diluted in ice-cold coating buffer. The solid support Tnay be incubated with this coating buffer, air dried, and sequence cross-linked to the solid support, for example by exposure to ultraviolet light for an ~lu~,l amount to time 15 to allow for efficient cross-linking. The solid support may be washed with a~ lUlJI buffer and m,.~ ir~,, attachment sites blocked by incubation with l.ybli " solution, including protein blocking reagent, following by washing, air-drying, and storage under ~
conditions until use t see P. Tijssen, "Practice and Theory of Enzyme r y~ in R.H.
Burton and A.H. van ~nirpPnhPrg, eds., 15 Laboratory Techniques in Biul,}~ lly and Molecular Biology, (New York, Elsevier Publication 1985) at 549 illWI,U~ ' herein by reference].
T - ~ I ~PfPrfi~m of rT. . .~ rx Nucleic Ari~l SPqllpnrpe The RNA NASBA products are hybridized with a .' y DNA probe immobilized on a solid phase, and the resulting RNA:DNA hybrids are detected ~Iy using an antibody that recognizes the RNA:DNA hybrids. Such anti-RNA:DNA antibodies recognize and bind to the unique helix structure formed whenever RNA
3 o and DNA stral~ds base-pair with each other, regardless of the specific nucleotide sequence of the ~1~7416 .
h~ulidiLi.l~ strands. Thus, the anti-RNA:DNA hybrid antibody will be useful in the I assay of any NASBA product, provided that a suitable cu~ lelll.,ll~y DNA
probe is available for immobilization on the solid phase. The solid phase used for the ' ' of the DNA probe can be any suitable surface which will enable the binding of 5 DNA by either covalent or non-covalent bonds, including, but not limited to, plastic microtiter plates, Illi~ UI~ of nylon or nitrocellulose, llyJI~ c cloths, beads, etc. The immobilized DNA is any DNA segment in the single stranded form which is y to the amplicon ll~liL~ i' reaction product, but which does not contain sequences ~ y to the priming ~ .."~ used in the initial modified NASBA.
10 Thus, the ~iliL~ DNA can be created by isolation of a specific DNA fragment generated by restriction digestion, by the well know procedure of rol~.l,.,l~e Chain Reaction (as described in U.S. Patents 4,683,195 and 4,683,202), or by i~yll~ll~iLil.L~ an ~ ' using synthetic chemistry processes. DNA fragments originally in the double stranded form can be rendered single stranded by ~' ' (e.g. heating, alkali) prior to ' ~ iu.. on the solid phase.
15 In the i ' ' detection system, the RNA:DNA hybrids formed on the solid phase by reaction of the amplicon i i~ I product witb the ' ;1;~ DNA are detected by reaction with an anti-RNA:DNA hybrid antibody which is labelled with a detectable chemical moiety (e.g. enzyme, 11U~ c, etc.). Alternatively, an unlabelled anti-RNA:DNA hybrid antibody can be used, followed by detection of the antibody using a second anti-antibody labelled 20 with a detectable chemical moiety.
The present invention will now be illustrated, but is not intended to be limited, by the following examples.
25 ExamDle 1:
An example of a method of detecting the NASBA product is described where the RNAis detected using the anti-HNA antibody, in a microtiter plate assay.
30 The plasmid used as a template for l ' = was pEP20 (E. Emond, 1. Fliss and ~157~16 S. Pandian, ~ppl. Environ. Microbiol. 59: 2690-2697, 1993), which contains an insert of 784 bp, cloned into the vector pUC12. A 2 ,ul aliquot containing 0, 102, 104' 106 and 10~ molecules of P1- primed DNA as template was added directly to each 25 ,ul ( final volume) NASBA
reaction containing 40 mM Tris-CI pH 8.5, 12 mM MgCI2, SOmM KCI, 10 mM vliLllivll~
(DTT), 2mM of each rNTP, ImM of each dNTP, 0.2 fLM Pl primer, 0.2 ~m P2 primer, 15 %
(vol/vol) dimethyl sufoxide, 100 ,ug/ml bovine serum albumin, 8 units AMV reverse aDv, 0.1 unit E.coli RNase H 40 units T7 RNA ~vvl~ and 12.5 units RNasin The reaction was incubated at 40C for 90 min.
0 The Pl-primed DNA template was prepared by annealing Pl primer to linearized and heat-denatured plasmid DNA (pEP20), followed by DNA synthesis using 10 units of AMV
reverse l"" ~ . and NASBA reagents at 50C for 15 min. The P1 primed strand was separated by tllermal ~ ;.," and ' 'y chilled on ice to minimize ~ UldLivll of the DNA strands.
Analysis of the NASBA product r~c~. Fel 'vlvvhu~ . Two ~1 of eæh of the above NASBA reætions, vull~ r " g to varying amounts of the input P1 primed template was loaded on the agarose gel (0.7%). and the RNA reætion product was detected by ehidium bromide lluvlv~vv..vv. Figure 1 illustratvs the results. Lane 1: Molecular size markers (100 bp ladder), Lanes 2-6: NASBA reætion products, where the template DNA were 0, 102, 104' 106' and 10~ molecules respectively. It can be seen tbat tbe ~..I."lir has occurred in all the reactions (Lanes 3-6) exvept the control reaction (Lane 2).
25 2. HN~-El l.~. Into microtiter plate wells coated with capture probe DNA (: ,' y to the 784bp fragment of pEP20), 50 ~1 of h~ buffer was taken followed by the addition of ten f~l of eæh of the NASBA reætion products and 40 ~1 of RNase-free water. The plates were incubated for 9û min at 56C and then three times washed with TBST buffer. The following i ~ were carried out at room i ~ d~Ulv~ Anti-HNA antibody (100 ,ul; mouse 3 o monoclonal IgM) was added at d~)~)lU~I id~v dilution and incubated for 20 min. and then the plates 21~7416 were washed three times with TBST. Goat anti-mouse IgM - HRP conjugate (100 ,ul) was added and incubated for 20 min. and the unreacted conjugate was washed away as described above.
TMB microwell peroxidase substrate was added and the blue color was read at 540nm. The results are given in Table I and Figure 2. It can be seen that the NASBA reaction products can 5 be detected using the anti HNA-antibody or other reagents known in the art.
As disclosed in detail above, in one ,..ll.~.li,....,l of this invention the combined ~ ' and ~ ' assay procedure of the present invention can be applied to any instance where one wishes to employ the NASBA technique for the assay of a microbe 10 (bacteria, fungi, viruses, etc.) either directly or in an c... ' culture of a sample (e.g., food, clinical specimen, ~ t, etc.). This application will be ~.~u~il,ulally useful in the clinical (human medical and veterinary), agricultuMI (food safety, food industry) and ~,llVil~ ' ' (water systems, soils) fields, where it is often necessary to analyze samples for the presence of minute quantities of target cells (e.g. pathogens), and where the availability of an ul(~ ive and specific method would be pcui ' ly aJv In another ~ ~ ' t, the present system can be applied in the NASBA-based geneticanalysis of target cells (e.g., organs, tissues, cellular organelles, etc.) or specific genes. This application would enjoy many uses in the medical and biological fields, where it could be used 2 0 as a tool to aid in the diagnosis of genetic diseases or the ~ i. .., of genetic material in biological samples.
In yet another . ' ' t, the present invention can be applied in the NASBA-based analysis of target cells (e.g., microbes, eukaryotic cells, etc.) captured from a test sample on 25 a solid phase (e.g., ~ beads). This application would be of particular use in the ilubiologi~,dl, bi~,h~,l..;~l and medical fields, where it is often desirable to analyze for the presence of very low numbers of t~rget cells recovered from large volumes of sample (e.g., ~llViU~ l water samples, body fluids such as blood, etc.).
3 o Tbus, the principle of the present invention should be widely applicable not only to the 16 ~1~741~
detection of food pathogens such as L. I~u~o~,y tu~ s. but also in the analysis of a wide variety of other bacteria, fungi, viruses, etc., of clinical or economic interest.
From the foregoing d~ ir , one skilled in the art can easily ascertain the essential ~,ll~t~ ,s of this invention, and without departing from the spirit and scope thereof, can make various changes and 1..~ of the invention to adapt it to various usages andconditions. (~ ly~ such changes and -'~ are properly, equitably, and "intended" to be, within the full range of equivalence of the following claims.
METHOD FOR ENEIANCING DETECTION ABILITY OF NUCLEIC ACID ASSAYS
EMPLOYl~G NUCLEIC ACID SEQUENCE BASED AMPLIFICATION
BACKGROUND OF TEIE INVENTION
The present invention relates to improved methods of detecting specific nucleic acid sequences. Examples of nucleic acid sequences are d~-y~ ..u,,l~.~, acid (DNA) and ribonucleic acid (RNA) sequences. The molecular subunits of both DNA and RNA are called 10 nucleotides which are linked together to form long poly ' ' chains. Each nucleotide subunit is made of a sugar moiety, a phosphate moiety and a bæe moiety. It is the sequential ordering of the bæe moieties [adenine (A), cytosine (C), guanine (G), thymine (T), uracil (U)]
that contains DNA or RNA's genetic illrUl The ordering of these base moieties in a p~ly ' ' chain and the tendency of the bæes to attract and bond with other specific bæe 15 moieties, is exploited by this invention to locate, detect and isolate specific DNA or RNA
sequences.
DNA l-ormally contains two poly,.u.,l~,u~ , stMnds twisted about one another lengthwise in a helical manner resembling a ladder where the sides are made of identical sugar 2 0 (deu--y. il,~se) and phosphate molecules while the rungs are made up of bæes extending out from each stMnd, held together by weak attractive forces. In DNA, the base thymine on one stMnd always pairs with the bæe adenine on the opposing strand, and the base guanine always pairs with the bæe cytosine. This is called Culll~ lLaly bæe pairing.
RNA is also a p~ly ': '- strand. However, the sugar moiety is ribose (versus d~u~yl i~ose in DNA) and the bæes are adenine, guanine, cytosine and UMCil. In RNA, the bæe uracil on one strand can pair with the bæe adenine on the opposing stMnd, and the bæe guanine can pair with the bæe cytosine. Although RNA can pair with either a cc-~lr' y stMnd of RNA or DNA, it is normally single stMnded so does not form a helical structure.
2I~7~1 6 .
Techniques for detecting and/or isolating particular nucleic acid sequences of interest have increase~ in popularity during recent years especially in terms of application for detecting the presence of the DNA or RNA within pathogens such as viruses, bacteria, or other UU16~111;,~111~ and therefore the presence of these pathogens themselves. These techniques can 5 also be used for other purposes such as to screen bacteria for antibiotic resistance, to aid in the diagnosis of genetic disorders (for example in sickle cell anaemia and th~ ), and to detect cancerous cells. Several a~J~J' have been developed for the ~ ,lùbiu106i~,~1 analysis of clinical, food, Cl.viUI I, and forensic samples. A general review of a technique and its present and future v is provided in Bi~ nlngy (August 1983), pp. 471-478 0 which is i.,~ul,uul~L~d herein by reference.
One situation in which it is desired to detect the presence of target nucleic acids involves the detection of pathogens by means of diagnostic tesE which claims a large share of the health care market and the agri-food industry. The definitive ' ~ of microbial pathogens in i ~ ., ' (e.g., foods) and clinical specimens requires the observation of the infectious agents or their -~ ~lr , soch as specific antigens or nucleic acid (DNA or RNA) sequences. The traditional culture methods for the detection of pathogens are slow, expensive and labour-intensive.
2 o To overcome these di ,~lv ~ , simple and rapid methods exploiting new Ir~
have been developed for detecting the presence of pathogens of medical, c..~/iu~ ' and a6li ' ' importance which appear in sample matrices (e.g., foods) at very low Several ' O ' tests are now available which exploit the specificity of the antibody-antigen reaction, namely, ~' tests, nuul~...,e tests and ~., (e.g., Id.li~ ~, enzyme ~,.).
~ " y employs a radioactive isotope as the label. Because of the ;II~UA.~. , hazard and difficulty of handling radioactive materials, assay systems have been devised using labels other than ,~ ,.- as the label comronPnt, including enzymes, 3 o 1,~~ , metals and organo-metallic comple~es, co-enzymes, enzyme substrates, enzyme ~1~7416 activators and inhibitors, rh~mil ' ' reactants, fluorescent molecules, and others.
Enzyme ~O use enzyme-labelled ~Cllio (antibodies or antigens) for detection of antigens or antibodies captured on a solid phase. In this technique, enzymes (e.g., 5 peroxidase, alkaline 1' . ' ) are covalently linked to a detector ~g~ (e.g., an antigen-specific antibody) by using a cross-linking agent, such as, ' ' ' ' yJ~ or a procedure such as periodate oxidation. Adsorption onto an easily l~iCu..,l~le solid phase provides for a simple and rapid means of ~;li~iu.. of VU,~ I for the subsequent capture of antigens or antibodies from a test sample. Since antibodies and antigens contain l~yd~ ic 10 regions in their structures, they bind readily to l~yJIu~Jll~ic surfaces. Most commonly used enzyme y~ depend on the adsorption of ~Ab~ onto either a flat solid phase, a ~UIUUo surface, or a Il~ ,lUlJVIUUo surface such as polyester cloth. Solid phases, e.g., microtiter plates, tubes or beads, and plastics, e.g., pulyoIyl~ " polyvinyl chloride, nylon and poly,l,~ "y' have been commonly used.
Another approach commonly used for pathogen detection involves the use of a nucleic acid probe (DNA or RNA) labelled with a detector moiety (e.g., ~ , chemical label such as ~'iv v or biotin, enzymes, fluorescent markers, etc.), which can be hybridized with IIUE,~.. specific nucleic acid sequences ' ~ 1 on a solid phase (e.g., membrane or microtiter plate). The hybridized probe is then measured by detecting the presence of the detector moiety.
Yet another more recently developed approach for detecting pathogens involves the use of nucleic acid sequence based ~ lirl~ iull (NASBA), described in United States patent 5,409,818 for the a"",l ~ of unique nucleic acid sequences of bacteria and other t~rget cells. The advantages and limitations of this technique have been reviewed by van Gemen (J.
Virol. Metho~s, 43: 117-188, 1993, i,.~u,~ ' herein by reference). This powerfultechnique, which uses can achieve ~..,.,.~,..Ju . amplification of very low numbers of target nucleic acids to levels which can be easily visualized by vl~llU~lllUl~ analysis or by 30 llybli.li~dtiOIl with a DNA probe.
~ 2~7~16 The . ' of specific RNA sequences generated by the NASBA technique has been widely applied to the rapid and sensitive detection of bacterial pathogens. Although NASBA has great potential as a very sensitive and specific technique, it has not always been possible to ællieve this level of sensitivity in its application to the detection of pathogens directly 5 or in U.ll ' cultures of food and e.~ ' samples.
The sensitivity of the NASBA could be enhanced by detection of the product using DNA
probes tdrgeting the amplified sequences (such as the ' ' 'o,,y described in Holstrom 11..
1993, Anal. Biochem., 209:278-283). However, such methods usually involve labour-intensive 0 DNA-DNA l~ylJIiJ;~Liu procedures and require the use of probes labelled with detectable chemical or radioactive moieties, which can be costly to prepare and difficult to ~ Ldi~.
r, Lh~,,l.lUI~, DNA probes targeting the NASBA product sometimes only produce a moderate . U~ in the sensitivity of the test, which may still require more than ten to several hundred cells per reaction in order to give a detectable signal.
One way of enhancing signal amplification entails tdrgeting RNA. An example of target irl~liu., entails assaying for ribosomal RNA (rRNA) of a UUlo~lll; ..l rather than ' ul.lù ~VIlldl DNA. Since rRNA is present in any given cell at 104 times higher ~
than DNA, the number of possible target sequences increases, thereby increasing the probability 2 o of detecting the target organism. However, this approach suffers from the limitation of the type of RNA sequences being expressed and therefore not completely suitable.
Yet another i iL"iol~-based; .,lirl~Liu.l system utilising ~B-replicase can produce a 2-5 million-fold ~ rl~,iull of a given target after 4 cycles (Li~ardi et al., B- ' ' Oy 6, 1197-1202, 1988). However, this technique suffers from such problems as excessive noise, false positives, requires ~ ' ' ' technical expertise, and relatively expensive il..,.
and reaOents (Walcott et al. J. Food Prot. 54:387-401, 1991).
Accor~ingly, those concerned with the dl~v~ '(I and application of NASBA-based 3o diagnostic tests have recognized the need for simple, non-hazardous L~ for ~ v ~1~7416 .~
the sensitivity of NASBA tests. r. ih.,.lllvl~;, there is a great need for ~ methods for detecting pathogens, rather than the purely qualitative approaches currently being practised, since it is often necessary to estimate the degree of microbial hazard associated with a sample (e.g., foods) on the basis of the level of Therefore, there is a great need for simple and ill~.A~ methods to augment the sensitivity and reliability of NASBA tests, ~ ,ulally for the forensic sciences, the food industry, clinical d~licdLio.~ and other users who must routinely process large numbers of samples containing very few target cells. It is therefore an object of the present invention to 0 provide a method for the . ' of NASBA for specific pathogens without the need for ill~Vl~Ul~llil." hazardous " ~ "~ or expensive (and potentially umreliable) chemical labels in the nucleotide transcripts to permit their subsequent detection.
A furtller object of this invention is to provide a very simple and user-friendly detection 15procedure for the products of the NASBA.
Yet another object of this invention is to provide for the 4u~ liv~ assay of pathogens in a sample by using the combined target nucleotide; ' method and detection procedure described above.
~ , In accordance with the present invention and as used herein, the following terms are defined with the following meanings, unless explicitly stated otherwise.
The term "amplicon" refers to a fragment of DNA or RNA spanned within a pair of annealing primers; this fragment is amplified 1AIJV '' ~Iy by the enzyme DNA pol~-ll.,l~s~.
The term "i .: ' . ' " refers to a procedure for s ~ ~ 'y enhancing the number of copies of RNA sequences that are ~v~ y to DNA amplicon sequences ~1~741~
by ~ of those amplicon sequences into many copies of RNA by using an dl)lJlU~JI' ' RNA polymerase.
The term "lldiL~ i' I reaction mix" refers to RNase-free deionized distilled water containing 80 mM Tris-HCI (pH 7.5), 12 mM MgCIl, 4 mM ~. " , 20 mM NaCI, 20 mM
(1, 1 mM of each rNTP (Promega, No. P1221), 10 units of T7 RNA pOIylK~
(Promega, No. P2075) and 20 units of RNasin (Promega, Nû. N2511) per 25 ,ul).
The term "NASBA " refers to a process for amplifying a specific nucleic acid sequence, involving; ~y ' ~ single-stMnded RNA, single stranded DNA and double-stranded DNA;using the single-stranded RNA as a first template for a first primer, using the single-stranded DNA as a second template for a second primer, and using the double-stranded DNA
as a third template for synthesis of a pluMlity of copies of the first template; a sequence of the frst primer or the second primer is cu."~' y to the sequence of the target nucleic acid and a sequence of the first primer or the second primer is h~m~r~--c to a sequence of the target nucleic acid. NASBA is used to increase the quantity of the target nucleic acid sequence to allow detection or to increase the purity of such a target nucleic acid sequence.
The term "target nucleic acid sequence" refers to any DNA or RNA sequence that is desired to be detected.
SUMMARY OF TE~E INVENTION
This method applies to techniques that employ nucleic acid sequence based ~
(NASBA) to amplify copies of the target RNA or DNA to allow for detection. This method combines the following three steps for the first time: nucleic acid , ' ' using NASBA
of a target nucleic acid sequence; RNA:DNA hybrid formation; and ' ' detection of i,~,~,ludu~ ,A nucleic acid sequences. This metbod extends the standard NASBA techniques 2~S7~1 6 to r~ ---- ' ' the .~ r~ O~. of copies of the NASBA product, which, following binding to immobilized probe DNA sequences facilitates ' ' detection of the RNA:DNA
hybrids thereby formed.
FIGURES
Figure I is an Agarose gel Clc~,ll, . ' ~i~ of the NASBA reactions.
Figure 2 is graphic l~l~ of various COI~ " of NASBA products detected 0 by anti-HNA-antibody.
DETAILED DESCRIPTION OF THE INV~ON
The method described in this invention applies to techniques that employ nucleic acid 5 sequence based A~ lir~ . - (NASBA) to amplify copies of target RNA or DNA sequences to allow for their detection. This invention constitutes an exterlsion beyond the prior art rendering nucleic acid sequence detection more feasible and reliable while ~ improving thesignal-to-noise ratio of these techniques. This improvement is especially notable in situations where a target nucleic acid sequence is present as a minute component of a mixture of nucleic 2 o æid sequences or is present at low levels.
The method of the present invention combines the following three steps for the first time:
target nucleic acid ~ lirl~liol~ using NASBA; RNA:DNA hybrid formation; and - I detection of l~ `UdU~ A nucleic acid sequences. This method extends the 25 standard NASBA techniques to r ' ' the I .,lir~ ,.. of copies of NASBA RNA
product, which, following binding to DNA sequences facilitates ' ' detection of the RNA:DNA hybrids thereby formed.
In the first step of this invention, a nucleic æid sequence based r ~ l r ~' (NASBA) 30 process is used for amplifying a specific nucleic acid sequence, which involves: ~
2L ~7~ ~ 6 . ~
single-stranded RNA, single stranded DNA and double-stranded DNA;using the single-stranded RNA as a first template for a first primer, using the single-stranded DNA as a second template for a second primer, and using the double-stranded DNA as a third template for synthesis of a plurality of copies of the first template; a sequence of the first primer or the second primer is 5 : , l y to the sequence of the target nucleic acid and a sequence of the first primer or the second primer is l~n ~ ,JII!~ to a sequence of the target nucleic acid.
In the second step of this invention, RNA:DNA hybrid formation, advantage is taken of the fact that RNAis produced directly from NASBA, allowing the target nucleic acid sequences 0 to once again be selected out of b~h~,-uu--d nucleic acid sequences by ll,~/blil]i~illg the RNA
sequences to , ' y DNA probes attached to a solid support, to generate ' ili~d RNA:DNA hybrids. This allows for washing away of extraneous material.
The h~uduL~h,~ nature of the nucleic acids sequences allows for the use of antibûdies 15 that specifically recognize RNA:DNA hybrids and can be used to detect the hybrids in one of many ' ' methods of analysis. This antibody can possess a chemical group allowing for direct detection of the hybrids, or it can also be detected indirectly using another antibody to which a chemical group is attached, that recognizes the anti-RNA:DNA antibody.
t~; I r~r,~ - ,.1 Inll In one particular ~,...1,, ' ~, the sample to be tested is typically a piece of food, for example meat or cheese, or another source containing single or double stranded nucleic acids.
25 This includes ~ ,luu~ and/or other cellular material associated with these samples. The test sample is first treated to release the nucleic acids from the cells, followed by a step to denature the r~ucleic acids. This is typically accomplished by Iysing the cells in a Iysis buffer solution and the ~' of nucleic acids is preferably , ' ' ' by heating the resulting solution in boiling water or alkali treatment (e.g., 0.1 N sodium hydroxide). The denaturing step can often be used ' '~, with the Iysis method. The release of nucleic acids can, 21~ ~41 ~
.
also, be obtained through mechanical disruption such as free~ing/thawing, abrasion, sonication, physical/chemical disruption (eg. ~olyu~yc;al~lc.le ether detergents like Triton~, pulyu~.yal~ ulbiL~LIl detergents like Tween~, sodium dodecylsulfate, alkali treatment, osmotic shock, heat, or Iysing using enzymes such as proteinase K, Iysozyme, pepsin). The 5 resulting medium will contain nucleic acids in single stranded form which is then assayed according to present llyblidi~LIiu.. methods (Wang et al., Appl. Environ. Microbiol., 1992).
When the sample contains free single-stranded RNA sequences, the sample is in proper form for NASBA. If the sample contains a tuget sequence that is a free single-stranded DNA
10 sequence, then Lldl,.,~ iul. must first occur to generate the desired RNA sequence. When the assay is performed for detection of a Illi~,lU~ ,. , a bacterium for example, the cells must be Iysed and the nucleic acids have to be exposed in order to be available for llybl iJi~dtiu.. with the priming ~ . Methods of Iysis have been previously described and are well known to one skilled in the art.
RNA Amplifirotin~l ~ N~ R~
Target RNA is amplified by NASBA procedure (or the d~JlJlUlJI- ' RNA sequence must be generated from the target DNA). A standaud NASBA reaction mixture contains T7 RNA
20 pulyll.~.~se,RNaseH,AMVreverseLIdll,~ L~ nucleosideLlr~ ~' ,twoseparatespecific primers and dl~JIU~Jl buffer -ml One of the primers (Primer 1) is prepared with the T7 promotor sequence appended to its 5' end.. The reaction Lr ' has been previously described ( B. van Gemen et al, J. Vuol. Methods, 43: 177-188, 1993; European Patent No:
0329822).
In this process, single-stranded RNA is converted to single-stranded DNA which in turn is converted to a functional template for the synthesis of a plurality of copies of the original single-stranded RNA. A First primer and a second primer are used in the ~mrlifiroti~-~ process.
A sequence of the fust primer or the second primer is ,urrl~;~.lLly . y to a sequence 30 of the specific nucleic acid sequence and a sequence of the first or the second primer is 7 ~ 1 ~
sufficiently l~ ."~ to a sequence of the specific nucleic acid sequence. In some instances, both the first primer and second primer are rr ' '~ ' y and s~fr~
e.J--- to a sequence of the specific nucleic acid sequence, for example, if the specific nucleic acid sequence is double stranded DNA.
The RNA is converted to single-stranded DNA by l.yb- idi~ g an r~ ul ~rl~ primer(the first primer) to the RNA (the first template) and ~yllLh~i~illg a ~ . ' y strand of DNA from the first primer, (the first DNA sequence) by using a RNA-directed DNA
pol~ l~e. The resulting single-stranded DNA (the second template) is separated from the first template by, for example, hydrolysis of the first template and by using a l;l.. ". l;~.~ which is specific for 12NA-DNA hybrids (for e~ample, .i~ . H). The second template is converted to a form which is capable of RNA synthesis by l.~. idi~illg a syntbetic r~ ,J"", l~Ol ir~,S (the second primer), which contains at its 3' end a sequence which is rr- ~ Iy IL~Y to the 3' end of the second template and toward its 5' end a sequence containing 15 the antisense strand of a promoter and antisense sequence of a lldlr~ UliOI~ initiation site, and by Sy..a.~ i,.g a second DNA sequence covalently attached to the 3' end of the second primer using the second template as a template and ~ ih~i~illg a third DNA sequence covalently attached to the 3' end of the second template using the second primer as a templated, using DNA-directed DNA p~lylllci~. The resulting functional derivative of the second template, 20 which is a third template, is used for the synthesis of a plurality of copies of RNA, the first template, by using a RNA p~l~lll.,l~e which is specific for the promoter and LlL~ iUII
initiation site defined by the second primer. Each newly ~yllal~i~d first template can be converted to further copies of the second template and the third template by repeating the cycle.
In addition, repetition of the cycle does not require ~ ioll or . . I by the user.
RNA:DNA Hybri~l Forr~irn Once the NASBA method has generated an ~lUL" number of copies of the target nucleic acid sequences of interest, the NASBA products will be digested using an ~JIU~II' ' restriction; ' ' (eg. Hind lll) to cleave off the primer- l' y sequences, 215~41 6 leaving target-~ , ' y nucleic acid sequences for use as probes. These probes will be ~urr..,;~ ly long (typically greater than 16 nucleotides) and ~urr~ , ' y to thetarget nucleic acid sequences to allow for efficient binding of transcribed amplicons to generate T~NA:DNA hybrids.
The probes thereby created can be attached to solid supports such as microtiter wells, "dip sticks~, or III.I~,IUI,JvlU.I. polyester cloth. Modes of nucleic acid sequence attachment to various forms of solid supports are well known in the art. The primary objective of the mode of attachment chosen is to allow for secure attachment of the nucleic acid to the support while 10 allowing for future efficient binding of cu.ll~' y sequences.
The probe may be denatured by heating and then diluted in ice-cold coating buffer. The solid support Tnay be incubated with this coating buffer, air dried, and sequence cross-linked to the solid support, for example by exposure to ultraviolet light for an ~lu~,l amount to time 15 to allow for efficient cross-linking. The solid support may be washed with a~ lUlJI buffer and m,.~ ir~,, attachment sites blocked by incubation with l.ybli " solution, including protein blocking reagent, following by washing, air-drying, and storage under ~
conditions until use t see P. Tijssen, "Practice and Theory of Enzyme r y~ in R.H.
Burton and A.H. van ~nirpPnhPrg, eds., 15 Laboratory Techniques in Biul,}~ lly and Molecular Biology, (New York, Elsevier Publication 1985) at 549 illWI,U~ ' herein by reference].
T - ~ I ~PfPrfi~m of rT. . .~ rx Nucleic Ari~l SPqllpnrpe The RNA NASBA products are hybridized with a .' y DNA probe immobilized on a solid phase, and the resulting RNA:DNA hybrids are detected ~Iy using an antibody that recognizes the RNA:DNA hybrids. Such anti-RNA:DNA antibodies recognize and bind to the unique helix structure formed whenever RNA
3 o and DNA stral~ds base-pair with each other, regardless of the specific nucleotide sequence of the ~1~7416 .
h~ulidiLi.l~ strands. Thus, the anti-RNA:DNA hybrid antibody will be useful in the I assay of any NASBA product, provided that a suitable cu~ lelll.,ll~y DNA
probe is available for immobilization on the solid phase. The solid phase used for the ' ' of the DNA probe can be any suitable surface which will enable the binding of 5 DNA by either covalent or non-covalent bonds, including, but not limited to, plastic microtiter plates, Illi~ UI~ of nylon or nitrocellulose, llyJI~ c cloths, beads, etc. The immobilized DNA is any DNA segment in the single stranded form which is y to the amplicon ll~liL~ i' reaction product, but which does not contain sequences ~ y to the priming ~ .."~ used in the initial modified NASBA.
10 Thus, the ~iliL~ DNA can be created by isolation of a specific DNA fragment generated by restriction digestion, by the well know procedure of rol~.l,.,l~e Chain Reaction (as described in U.S. Patents 4,683,195 and 4,683,202), or by i~yll~ll~iLil.L~ an ~ ' using synthetic chemistry processes. DNA fragments originally in the double stranded form can be rendered single stranded by ~' ' (e.g. heating, alkali) prior to ' ~ iu.. on the solid phase.
15 In the i ' ' detection system, the RNA:DNA hybrids formed on the solid phase by reaction of the amplicon i i~ I product witb the ' ;1;~ DNA are detected by reaction with an anti-RNA:DNA hybrid antibody which is labelled with a detectable chemical moiety (e.g. enzyme, 11U~ c, etc.). Alternatively, an unlabelled anti-RNA:DNA hybrid antibody can be used, followed by detection of the antibody using a second anti-antibody labelled 20 with a detectable chemical moiety.
The present invention will now be illustrated, but is not intended to be limited, by the following examples.
25 ExamDle 1:
An example of a method of detecting the NASBA product is described where the RNAis detected using the anti-HNA antibody, in a microtiter plate assay.
30 The plasmid used as a template for l ' = was pEP20 (E. Emond, 1. Fliss and ~157~16 S. Pandian, ~ppl. Environ. Microbiol. 59: 2690-2697, 1993), which contains an insert of 784 bp, cloned into the vector pUC12. A 2 ,ul aliquot containing 0, 102, 104' 106 and 10~ molecules of P1- primed DNA as template was added directly to each 25 ,ul ( final volume) NASBA
reaction containing 40 mM Tris-CI pH 8.5, 12 mM MgCI2, SOmM KCI, 10 mM vliLllivll~
(DTT), 2mM of each rNTP, ImM of each dNTP, 0.2 fLM Pl primer, 0.2 ~m P2 primer, 15 %
(vol/vol) dimethyl sufoxide, 100 ,ug/ml bovine serum albumin, 8 units AMV reverse aDv, 0.1 unit E.coli RNase H 40 units T7 RNA ~vvl~ and 12.5 units RNasin The reaction was incubated at 40C for 90 min.
0 The Pl-primed DNA template was prepared by annealing Pl primer to linearized and heat-denatured plasmid DNA (pEP20), followed by DNA synthesis using 10 units of AMV
reverse l"" ~ . and NASBA reagents at 50C for 15 min. The P1 primed strand was separated by tllermal ~ ;.," and ' 'y chilled on ice to minimize ~ UldLivll of the DNA strands.
Analysis of the NASBA product r~c~. Fel 'vlvvhu~ . Two ~1 of eæh of the above NASBA reætions, vull~ r " g to varying amounts of the input P1 primed template was loaded on the agarose gel (0.7%). and the RNA reætion product was detected by ehidium bromide lluvlv~vv..vv. Figure 1 illustratvs the results. Lane 1: Molecular size markers (100 bp ladder), Lanes 2-6: NASBA reætion products, where the template DNA were 0, 102, 104' 106' and 10~ molecules respectively. It can be seen tbat tbe ~..I."lir has occurred in all the reactions (Lanes 3-6) exvept the control reaction (Lane 2).
25 2. HN~-El l.~. Into microtiter plate wells coated with capture probe DNA (: ,' y to the 784bp fragment of pEP20), 50 ~1 of h~ buffer was taken followed by the addition of ten f~l of eæh of the NASBA reætion products and 40 ~1 of RNase-free water. The plates were incubated for 9û min at 56C and then three times washed with TBST buffer. The following i ~ were carried out at room i ~ d~Ulv~ Anti-HNA antibody (100 ,ul; mouse 3 o monoclonal IgM) was added at d~)~)lU~I id~v dilution and incubated for 20 min. and then the plates 21~7416 were washed three times with TBST. Goat anti-mouse IgM - HRP conjugate (100 ,ul) was added and incubated for 20 min. and the unreacted conjugate was washed away as described above.
TMB microwell peroxidase substrate was added and the blue color was read at 540nm. The results are given in Table I and Figure 2. It can be seen that the NASBA reaction products can 5 be detected using the anti HNA-antibody or other reagents known in the art.
As disclosed in detail above, in one ,..ll.~.li,....,l of this invention the combined ~ ' and ~ ' assay procedure of the present invention can be applied to any instance where one wishes to employ the NASBA technique for the assay of a microbe 10 (bacteria, fungi, viruses, etc.) either directly or in an c... ' culture of a sample (e.g., food, clinical specimen, ~ t, etc.). This application will be ~.~u~il,ulally useful in the clinical (human medical and veterinary), agricultuMI (food safety, food industry) and ~,llVil~ ' ' (water systems, soils) fields, where it is often necessary to analyze samples for the presence of minute quantities of target cells (e.g. pathogens), and where the availability of an ul(~ ive and specific method would be pcui ' ly aJv In another ~ ~ ' t, the present system can be applied in the NASBA-based geneticanalysis of target cells (e.g., organs, tissues, cellular organelles, etc.) or specific genes. This application would enjoy many uses in the medical and biological fields, where it could be used 2 0 as a tool to aid in the diagnosis of genetic diseases or the ~ i. .., of genetic material in biological samples.
In yet another . ' ' t, the present invention can be applied in the NASBA-based analysis of target cells (e.g., microbes, eukaryotic cells, etc.) captured from a test sample on 25 a solid phase (e.g., ~ beads). This application would be of particular use in the ilubiologi~,dl, bi~,h~,l..;~l and medical fields, where it is often desirable to analyze for the presence of very low numbers of t~rget cells recovered from large volumes of sample (e.g., ~llViU~ l water samples, body fluids such as blood, etc.).
3 o Tbus, the principle of the present invention should be widely applicable not only to the 16 ~1~741~
detection of food pathogens such as L. I~u~o~,y tu~ s. but also in the analysis of a wide variety of other bacteria, fungi, viruses, etc., of clinical or economic interest.
From the foregoing d~ ir , one skilled in the art can easily ascertain the essential ~,ll~t~ ,s of this invention, and without departing from the spirit and scope thereof, can make various changes and 1..~ of the invention to adapt it to various usages andconditions. (~ ly~ such changes and -'~ are properly, equitably, and "intended" to be, within the full range of equivalence of the following claims.
Claims (3)
1. A method of nucleic acid sequence detection comprising the steps:
a) RNA amplification utilizing nucleic acid sequence based amplifications;
b) formation of RNA:DNA hybrids; and c) immunochemicals detection of RNA:DNA hybrids using procedures comprising antibodies directed to RNA:DNA hybrids.
a) RNA amplification utilizing nucleic acid sequence based amplifications;
b) formation of RNA:DNA hybrids; and c) immunochemicals detection of RNA:DNA hybrids using procedures comprising antibodies directed to RNA:DNA hybrids.
2. A method as claimed in claims 1, wherein the RNA:DNA hybrid formation has one of the nucleic acid sequences attached to a solid support.
3. A method as claimed in claims 1 or 2, wherein the immunochemical detection isperformed by a monoclonal or polyclonal antibody that recognizes the target RNA:DNA hybrid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002157416A CA2157416A1 (en) | 1995-09-01 | 1995-09-01 | Method for enhancing detection ability of nucleic acid assays employing nucleic acid sequence based amplification |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002157416A CA2157416A1 (en) | 1995-09-01 | 1995-09-01 | Method for enhancing detection ability of nucleic acid assays employing nucleic acid sequence based amplification |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2157416A1 true CA2157416A1 (en) | 1997-03-02 |
Family
ID=4156534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002157416A Abandoned CA2157416A1 (en) | 1995-09-01 | 1995-09-01 | Method for enhancing detection ability of nucleic acid assays employing nucleic acid sequence based amplification |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2157416A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0938320A1 (en) * | 1996-03-26 | 1999-09-01 | Michael S. Kopreski | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
-
1995
- 1995-09-01 CA CA002157416A patent/CA2157416A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0938320A1 (en) * | 1996-03-26 | 1999-09-01 | Michael S. Kopreski | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
EP0938320A4 (en) * | 1996-03-26 | 2006-09-06 | Michael S Kopreski | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
EP0938320B2 (en) † | 1996-03-26 | 2014-06-18 | Michael S. Kopreski | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5827661A (en) | Enhancing detection polymerase chain reaction assays by RNA transcription and immunodetection of RNA:DNA hybrids | |
US5627030A (en) | Method of amplification for increasing the sensitivity of detecting nucleic acid-probe target hybrids | |
KR0173133B1 (en) | Polynucleotide capture assay employing in vitro amplification | |
EP0876510B1 (en) | Homogeneous amplification and detection of nucleic acids | |
US9902993B2 (en) | Hyperthermophilic polymerase enabled proximity extension assay | |
EP0510085B1 (en) | Dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays | |
EP3323896A2 (en) | Exonuclease enabled proximity extension assays | |
EP0163220B1 (en) | Nucleic acid hybridization assay employing detectable anti-hybrid antibodies | |
EP0427074A2 (en) | Nucleic acid amplification employing transcribable hairpin probe | |
JPH09503910A (en) | Oligonucleotides and methods for the detection of Trachoma chlamydia | |
AU656965B2 (en) | Detection of DNA/RNA by fluorescence polarization | |
JPH0669374B2 (en) | Amplification of nucleic acid sequences using random sequence oligonucleotides as primers | |
WO2017068116A1 (en) | Method for generating proximity probes | |
CA2004326A1 (en) | Assay of sequences using amplified genes | |
US5981171A (en) | Diagnostic assays using nucleic acid probes | |
JPH0714359B2 (en) | Method for producing modified nucleic acid | |
CA2157416A1 (en) | Method for enhancing detection ability of nucleic acid assays employing nucleic acid sequence based amplification | |
EP2105741B1 (en) | Use of a virus expressing a binding moiety to measure analytes in a sample | |
US6306657B1 (en) | Polynucleotide probe and kit for amplifying signal detection in hybridization assays | |
WO1989009281A1 (en) | Method for amplifying and detecting nucleic acid in a test liquid | |
JP2001013139A (en) | Immunological measuring method | |
US7118864B2 (en) | Amplifiable probe | |
Owen | Techniques for Detection of Specific Organisms and Potential for DNA-Based Technologies | |
JP2005110664A (en) | Method for detecting presence of target dna by amplification of nucleic acid signal, and method for detecting or determining immunological ligand |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |
Effective date: 20061026 |